兰德-通过欧盟生物技术法案保护创新-兰德欧洲公司提交的证据（英）

Safeguarding Innovation through the EU Biotech ActHampton Toole, Jessica Dawney, Sana Zakaria, Devika Kapoor, Toby Webster, Sarah ParkinsonPE-A4203-1Prepared for the European Commission EU Biotech Act initiative Evidence submission by RAND EuropeExpert InsightsPERSPECTIVE ON A TIMELY POLICY ISSUEFor more information on this publication, visit www.rand.org/t/PEA4203-1About RAND Europe RAND Europe is a not-for-profit research organisation that helps improve policy and decision making through research and analysis. To learn more about RAND Europe, visit www.randeurope.org.Research Integrity Our mission to help improve policy and decision making through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behaviour. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/research-integrity.RAND’s publications do not necessarily reflect the opinions of its research clients and sponsors.Published by the RAND Corporation, Santa Monica, Calif., and Cambridge, UK© 2025 RAND CorporationR® is a registered trademark.Limited Print and Electronic Distribution Rights This publication and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorised posting of this publication online is prohibited; linking directly to its webpage on rand.org is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research products for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.1 Safeguarding Innovation through the EU Biotech Act Written evidence submitted by Hampton Toole, Jessica Dawney, Sana Zakaria, Devika Kapoor, Toby Webster, Sarah Parkinsoni RAND Europeii Prepared for the European Commission EU Biotech Act initiative June 2025 This document provides RAND Europe’s submission of evidence in relation to the European Commission’s EU Biotech Act call for evidence. This document is structured to reflect the questions in the committee’s call for evidence.iii Introduction RAND Europe is a not-for-profit, independent research organisation with offices in Cambridge, Brussels and the Hague. Our mission is to help improve policy and decision making through research and analysis. We have a subs